Macro & Micro-Test facilitates rapid screening of monkeypox

On 7th May, 2022, a local case of monkeypox virus infection was reported in the UK.

According to Reuters, on the 20th local time, with more than 100 confirmed and suspected cases of monkeypox in Europe, World Health Organization confirmed that an emergency meeting on monkeypox would be held on the same day. At present, it has involved many countries including the United Kingdom, the United States, Spain, etc. A total of 80 monkeypox cases and 50 suspected cases have been reported worldwide.

Macro & Micro-Test facilitates rapid screening of monkeypox1

Distribution Map of Monkeypox Epidemic in Europe and America by 19th May

Monkeypox is a rare viral zoonotic disease that usually spreads among monkeys in Central and West Africa, but occasionally to humans. Monkeypox is a disease caused by monkeypox virus, which belongs to the orthopox virus subgenus of the Poxviridae family. In this subgenus, only  smallpox virus, cowpox virus, vaccinia virus and monkeypox virus can cause human infection. There is cross immunity between the four viruses. Monkeypox virus is rectangular in shape and can grow in Vero cells, causing cytopathic effects.

Macro & Micro-Test facilitates rapid screening of monkeypox2

Electron microscope images of mature monkeypox virus (left) and immature virions (right)

Humans are infected with monkeypox, mainly through the bite of an infected animal, or direct contact with the blood, body fluids, and monkeypox lesions of an infected animal. Usually the virus is transmitted from animals to humans, and occasionally human-to-human infection can also occur. It is generally believed to be transmitted through toxic respiratory droplets during direct, prolonged face-to-face contact. In addition, monkeypox can also be spread through direct contact with an infected person's body fluids or virus-contaminated items such as clothing and bedding.

UKHSA said that initial symptoms of monkeypox infection include fever, headache, muscle aches, back pain, swollen lymph nodes, chills and fatigue. Patients also sometimes develop a rash, usually first on the face and then on other parts of the body. Most infected people recover within a few weeks, but others develop severe illness. In view of the successive reports of monkeypox cases in many countries, the development of rapid detection kits is urgently needed to avoid the rapid spread of the virus.

The Monkeypox Virus Nucleic Acid Detection Kit (Fluorescence PCR) and Orthopox Virus Universal Type/Monkeypox Virus Nucleic Acid Detection Kit (Fluorescence PCR) developed by Macro-micro Test help to detect monkeypox virus and find monkeypox infection cases in time.

The two kits can respond to the different needs of customers, help the rapid diagnosis of infected patients, and greatly improve the success rate of treatment.

Product Name

Strength

Monkeypox Virus Nucleic Acid Detection Kit (Fluorescence PCR)

50 tests/kit

Orthopox Virus Universal Type/Monkeypox Virus Nucleic Acid Detection Kit (Fluorescence PCR)

50 tests/kit

● Orthopox Virus Universal Type/Monkeypox Virus Nucleic Acid Detection Kit (Fluorescence PCR) can cover the four types of orthopoxviruses that cause human infection, and at the same time detect the currently popular monkeypox virus to make the diagnosis more accurate and avoid missing. In addition, one tube of reaction buffer is used, which is easy to operate and saves costs.
● Use rapid PCR amplification. The detection time is short, and the results can be obtained in 40 minutes.
● The internal control is introduced to the system which can monitor the whole test process and ensure the test quality.
● High specificity and high sensitivity. The virus can be detected at a concentration of 300Copies/mL in the sample. The monkeypox virus detection has no cross with smallpox virus, cowpox virus, vaccinia virus, etc.
● Two test kits can meet different needs of costumers.


Post time: Aug-01-2022